no2koolaid, are you aware that DCVax has “orphan drug designation” in the US? It will be exempt from the negotiation process under The Inflation Reduction Act, so this should not be an immediate concern for Northwest Bio or their shareholders.
True if and only if it is approved for nGBM only.
* Drugs that have received an “orphan drug” designation for only one rare disease or condition and the only approved indication(s) is for such disease or condition